These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Immunoregulatory T-cell function in acute and chronic liver disease. Kakumu S; Yata K; Kashio T Gastroenterology; 1980 Oct; 79(4):613-9. PubMed ID: 6967838 [TBL] [Abstract][Full Text] [Related]
26. [Comparative study of hemostatic changes in acute viral hepatitis and terminal cirrhosis]. Lemberg A; Bengochea L; Pierangeli N Acta Gastroenterol Latinoam; 1982; 12(4):371-5. PubMed ID: 7185233 [TBL] [Abstract][Full Text] [Related]
27. [IgG, IgA and IgM dysproteinemia in viral hepatitis correlated with hepatitis B blood antigens as a function of liver parenchymal damage]. Rzewnicki I Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1982; 27():137-51. PubMed ID: 6820830 [No Abstract] [Full Text] [Related]
29. [Immunological reactivity indices of the body in chronic liver disease patients before and after surgery]. Barskiĭ AV; Stoliarov EA Vestn Khir Im I I Grek; 1984 Jul; 132(7):97-8. PubMed ID: 6474751 [No Abstract] [Full Text] [Related]
30. Prevalence of herpesviridae and hepatitis virus sequences in the livers of patients with fulminant hepatitis of unknown etiology in Japan. Ishikawa K; Hasegawa K; Naritomi T; Kanai N; Ogawa M; Kato Y; Kobayashi M; Torii N; Hayashi N J Gastroenterol; 2002; 37(7):523-30. PubMed ID: 12162410 [TBL] [Abstract][Full Text] [Related]
31. Study of serum prealbumin and serum alpha fetoprotein in cases of fulminant hepatic failure. Jain SK; Rohatgi A; Raman KK; Sharma VK J Assoc Physicians India; 1995 Jul; 43(7):462-3. PubMed ID: 8713217 [TBL] [Abstract][Full Text] [Related]
32. [Selected factors of nonspecific humoral immunity in patients with viral hepatitis]. Mierwa A Pol Tyg Lek; 1983 May 16-23; 38(20-21):629-31. PubMed ID: 6647125 [No Abstract] [Full Text] [Related]
33. Clinical significance of serum soluble Fas ligand in patients with acute self-limited and fulminant hepatitis. Shiota G; Oyama K; Noguchi N; Takano Y; Kitaoka S; Kawasaki H Res Commun Mol Pathol Pharmacol; 1998 Jul; 101(1):3-12. PubMed ID: 9755839 [TBL] [Abstract][Full Text] [Related]
36. Impact of viral hepatitis on apo- and lipoprotein status in blood. Irshad M; Dube R; Joshi YK Med Princ Pract; 2007; 16(4):310-4. PubMed ID: 17541298 [TBL] [Abstract][Full Text] [Related]
37. Studies on pokeweed mitogen-induced lymphocyte proliferation in viral hepatitis. Szkaradkiewicz A; Kiczka W; Trejster E Arch Immunol Ther Exp (Warsz); 1983; 31(4):505-9. PubMed ID: 6686929 [TBL] [Abstract][Full Text] [Related]
38. [Cellular and humoral immune studies in acute viral hepatitis]. Stanciu L; Cîrstina D; Părău N; Radu D; Dejica D; Gorgan V; Urcan S Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(4):349-56. PubMed ID: 6140733 [No Abstract] [Full Text] [Related]
39. Pathology and pathogenesis of fulminant hepatic failure--a review of 100 cases. Aikat BK; Pandit VL; Das Gupta AD; Pal SR; Sehgal S; Pathania AG; Chhuttani PN; Datta DV Indian J Med Res; 1979 Jul; 70():107-15. PubMed ID: 500149 [No Abstract] [Full Text] [Related]
40. Combined traditional Chinese and western medicine in subacute hepatic necrosis due to acute virus hepatitis. A clinical study. Chin Med J (Engl); 1978 Jul; 4(4):261-5. PubMed ID: 100285 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]